SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-060281
Filing Date
2024-07-10
Accepted
2024-07-10 08:00:33
Documents
15
Period of Report
2024-07-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209181-8k_longeveron.htm   iXBRL 8-K 26286
2 PRESS RELEASE ISSUED BY THE COMPANY ON JULY 10, 2024 ea020918101ex99-1_longeveron.htm EX-99.1 16233
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3035
  Complete submission text file 0001213900-24-060281.txt   228724

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20240710.xsd EX-101.SCH 3021
5 XBRL LABEL FILE lgvn-20240710_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lgvn-20240710_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209181-8k_longeveron_htm.xml XML 3774
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 241108711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)